Zinc supplementation to HIV-1-infected pregnant women: Effects on maternal anthropometry, viral load, and early mother-to-child transmission

European Journal of Clinical Nutrition

Volumn 60, Issue 7, 2006, Pages 862-869

  Villamor, E ^a   Aboud, S ^b   Koulinska, I N ^a   Kupka, R ^a   Urassa, W ^b   Chaplin, B ^a   Msamanga, G ^b   Fawzi, W W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

HIV infection; Mother to child transmission; Pregnancy; Viral load; Wasting; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYANOCOBALAMIN; FERROUS SULFATE; FOLIC ACID; MULTIVITAMIN; NEVIRAPINE; NICOTINIC ACID; PLACEBO; PYRIDOXINE; RIBOFLAVIN; THIAMINE; ZINC; ZINC SULFATE;

ADULT; ANTHROPOMETRY; ARM CIRCUMFERENCE; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FETUS OUTCOME; GESTATION PERIOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TANZANIA; VIRUS LOAD; VIRUS TRANSMISSION; WASTING SYNDROME;

ADULT; ANTHROPOMETRY; DISEASE TRANSMISSION, VERTICAL; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TANZANIA; VIRAL LOAD; ZINC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745698863     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602391     Document Type: Article

References (40)

1. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S et al. (2004). Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114, 370-378.
2. Baum M, Cassetti L, Bonvehi P, Shor-Posner G, Lu Y, Sauberlich H (1994). Inadequate dietary intake and altered nutrition status in early HIV-1 infection. Nutrition 10, 16-20.
3. Baum MK, Campa A, Lai S, Lai H, Page JB (2003). Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Clin Infect Dis 37 (Suppl 2), 117S-123S.
4. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA et al. (1997a). High risk of HIV-related mortality is associated with selenium deficiency. J Acquired Immune Defic Syndr Hum Retrovirol 15, 370-374.
5. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA et al. (1995). Micronutrients and HIV-1 disease progression. AIDS 9, 1051-1056.
6. Baum MK, Shor-Posner G, Zhang G, Lai H, Quesada JA, Campa A et al. (1997b). HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquired Immune Defic Syndr Hum Retrovirol 16, 272-278.
7. Beach RS, Mantero-Atienza E, Shor-Posner G, Javier JJ, Szapocznik J, Morgan R et al. (1992). Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 6, 701-708.
8. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ (1997). Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 272, E1002-E1007.
9. Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM, Hidayat A et al. (2000). Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: Pooled analysis of randomized controlled trials. Am J Clin Nutr 72, 1516-1522.
10. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A et al. (1999). Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 135, 689-697.
11. Bobat R, Coovadia H, Stephen C, Naidoo KL, McKerrow N, Black RE et al. (2005). Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: A randomised double-blind placebo-controlled trial. Lancet 366, 1862-1867.
12. Bogden JD, Baker H, Frank O, Perez G, Kemp F, Bruening K et al. (1990). Micronutrient status and human immunodeficiency virus (HIV) infection. Ann NY Acad Sci 587, 189-195.
13. Bogden JD, Kemp FW, Han S, Li W, Bruening K, Denny T et al. (2000). Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr 72, 809-815.
14. Brown KH (1998). Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. Am J Clin Nutr 68, 425S-429S.
15. Diggle PJ, Heagerty P, Liang K, Zeger S (2002). Analysis of Longitudinal Data. Oxford University Press: Oxford.
16. Fawzi WW, Msamanga G, Hunter D, Urassa E, Rengifo B, Mwakagile D et al. (2000). Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 23, 246-254.
17. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D et al. (1998). Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477-1482.
18. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E et al. (2004). A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 351, 23-32.
19. Fawzi WW, Villamor E, Msamanga GI, Antelman G, Aboud S, Urassa W et al. (2005). Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr 81, 161-167.
20. Graham NM, Sorensen D, Odaka N, Brookmeyer R, Chan D, Willett WC et al. (1991). Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 4, 976-980.
21. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354, 795-802.
22. International Zinc Nutrition Consultative Group (IZiNCG) (2004). Assessment of the risk of zinc deficiency in populations. Food Nutr Bull 25, 130S-162S.
23. James WPT, Mascie-Taylor GCN, Norgan NG, Bistrian BR, Shetty PS, Ferro-Luzzi A (1994). The value of arm circumference measurements in assessing chronic energy deficiency in Third World adults. Eur J Clin Nutr 48, 883-894.
24. Jiamton S, Pepin J, Suttent R, Filteau S, Mahakkanukrauh B, Hanshaoworakul W et al. (2003). A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS 17, 2461-2469.
25. Kelly P, Musonda R, Kafwembe E, Kaetano L, Keane E, Farthing M (1999). Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: A randomized controlled trial. AIDS 13, 495-500.
26. Koch J, Neal EA, Schlott MJ, Garcia-Shelton YL, Chan MF, Weaver KE et al. (1996). Zinc levels and infections in hospitalized patients with AIDS. Nutrition 12, 515-518.
27. Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A et al. (1992). Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 116, 320-328.
28. Mantzoros CS, Prasad AS, Beck FW, Grabowski S, Kaplan J, Adair C et al. (1998). Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 17, 270-275.
29. Mocchegiani E, Veccia S, Ancarani F, Scalise G, Fabris N (1995). Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 17, 719-727.
30. Ramboarina S, Druillennec S, Morellet N, Bouaziz S, Roques BP (2004). Target specificity of human immunodeficiency virus type 1 NCp7 requires an intact conformation of its CCHC N-terminal zinc finger. J Virol 78, 6682-6687.
31. Shankar AH, Prasad AS (1998). Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr 68, 447S-463S.
32. Tamura T, Goldenberg RL (1996). Zinc nutriture and pregnancy outcome. Nutr Res 16, 139-181.
33. Tanchou V, Decimo D, Pechoux C, Lener D, Rogemond V, Berthoux L et al. (1998). Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J Virol 72, 4442-4447.
34. Tang AM, Graham NMH, Kirby AJ, McCall AD, Willett WC, Saah AJ (1993). Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 138, 1-15.
35. Tang AM, Graham NMH, Saah AJ (1996). Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 143, 1244-1256.
36. Villamor E, Msamanga G, Spiegelman D, Antelman G, Hunter DJ, Peterson KE et al. (2002a). Effect of multivitamin and vitamin A supplements on weight gain during pregnancy among HIV-1 infected women. Am J Clin Nutr 76, 1082-1090.
37. Villamor E, Msamanga G, Spiegelman D, Coley J, Hunter DJ, Peterson KE et al. (2002b). HIV status and sociodemographic correlates of maternal body size and wasting during pregnancy. Eur J Clin Nutr 56, 415-424.
38. White H (1980). A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48, 817-830.
39. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A et al. (2001). High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 167, 4593-4599.
40. Zijenah LS, Moulton LH, Iliff P, Nathoo K, Munjoma MW, Mutasa K et al. (2004). Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe. Aids 18, 273-280.